PT-141 is a non-hormonal therapy that represents a major shift in how we approach female sexual desire
Int J Mol Sci 24:2633 EFSA Panel on Nutrition NF and FA (NDA), Turck D, Bohn T et al (2023) Scientific opinion on the tolerable upper intake level for selenium
Why do patients stop GLP-1 drugs
Setting realistic expectations is crucial: weight loss is gradual, with clinical trials showing approximately 15% weight reduction with semaglutide 2.4 mg at 68 weeks and up to 21% with tirzepatide at 72 weeks, though individual responses vary considerably
Menopause and GLP-1: So, What Role Can They Play
At the molecular level, The compound has been shown to reduce production of tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and other pro-inflammatory cytokines